Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

45.12
-0.2100-0.46%
Pre-market: 45.660.5400+1.20%06:02 EDT
Volume:9.36M
Turnover:425.05M
Market Cap:199.57B
PE:11.27
High:46.16
Open:45.80
Low:45.07
Close:45.33
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:0.87
T/O Rate:0.29%
Dividend:1.72
Dividend Rate:3.82%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.13
PE(LYR):12.46

Loading ...

Novo Nordisk A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
May 30

Jefferies Reaffirms Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
May 29

Novo Nordisk Receives Indian Approval for Wegovy in Adolescents

Deep News
·
May 29

CVS Health Reinstates Coverage for Eli Lilly's Zepbound and Adds New Oral Weight-Loss Drug to Formulary

Deep News
·
May 29

Novo Nordisk A/S Stock Rises Thursday, Outperforms Market

Dow Jones
·
May 29

Movement Alert|Novo Nordisk Rises 3.18% in Regular Trading, EASL Conference MASH Data and Acquisition Rumors Boost Sentiment

Market Focus
·
May 28

Deutsche Bank Sticks to Its Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
May 28

Novo Nordisk Advances Oral Wegovy Lead As Investor Focus Shifts To Uptake

Simply Wall St.
·
May 28

France to reimburse weight-loss drugs from mid-June, health minister says

Reuters
·
May 28

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 1.46%

TIPRANKS
·
May 28

Novo Nordisk to showcase new data from its cardiometabolic portfolio at ADA

TIPRANKS
·
May 27

Sector Update: Healthcare

MT Newswires Live
·
May 27

Novo Nordisk A/S Stock Falls Tuesday, Underperforms Market

Dow Jones
·
May 27

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

MT Newswires Live
·
May 26

Market Chatter: Generic Copy of Novo Nordisk's Ozempic Shot Approved in Brazil

MT Newswires Live
·
May 26

Generic Copy of Novo Nordisk's Ozempic Shot Approved by Brazil, Bloomberg Reports

MT Newswires Live
·
May 26

Does Medicine's New Obsession Really Work? -- Barrons.com

Dow Jones
·
May 26

Oral Wegovy And Cancer Signals Reframe Novo Nordisk GLP 1 Opportunity

Simply Wall St.
·
May 26

Kepler Capital Keeps Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
May 24

Does Medicine's New Obsession Really Work? -- Barron's

Dow Jones
·
May 23